相关实验视频
Updated: Jul 2, 2025
13:25
Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
Published on: May 15, 2021
5.7K
坎德沙坦通过GDF-15通路保护对西斯普拉丁诱导的损伤
1Department of Medical Oncology, Medical Point Hospital, University of Economy, Izmir, Turkey. gurkan.guner@izmirekonomi.edu.tr.
European review for medical and pharmacological sciences
|February 20, 2024
概括
坎德沙坦通过增加生长分化因子15 (GDF-15) 和减少炎症和氧化应激来保护对甲诱导的损伤.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 西斯普拉丁是一种广泛使用的化疗剂,具有显著的毒副作用.
- 确定减轻西斯普拉丁诱导损伤的策略对于改善患者的治疗结果至关重要.
- 增长分化因子15 (GDF-15) 在保护中的作用需要进一步研究.
研究的目的:
- 调查沙坦对西斯普拉丁诱导的毒性产生的保护作用.
- 探索GDF-15途径在坎德沙坦的脏保护机制中的参与.
主要方法:
- 成年雌性Wistar大鼠被给予西斯来诱导脏损伤.
- 动物接受了康德沙坦或安慰剂 (自来水) 的治疗.
- 评估了组织学,血清肌素,甲 (MDA),瘤缩因子-α (TNF-α),介素-6 (IL-6) 和GDF-15水平.
主要成果:
- 坎德沙坦治疗显著降低了MDA,TNF-α,IL-6和肌素的血清水平,与仅服用西斯的组相比.
- 在接受坎德沙坦治疗的老鼠中,血清GDF-15水平显著升高.
- 组织病理学检查证实,坎德沙坦能预防损伤.
结论:
- 坎德沙坦显示显著的脏保护作用,防止西斯普拉丁诱导的脏毒性.
- 该机制涉及增加GDF-15水平,降低炎症标志物的调节,并减少氧化应激.
- 坎德沙坦是一种潜在的治疗策略,可以缓解化疗相关的损伤.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
638
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
638
01:25Antihypertensive Drugs: Direct Renin Inhibitors
629
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
629
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
731
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
731
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
554
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
554